Tech Company Financing Transactions
Athenix Funding Round
Finistere Ventures, Boston Millennia Partners and Covera Ventures participated in a $13 million Series C funding round for Athenix. The round closed on 1/6/2006.
Transaction Overview
Company Name
Announced On
1/6/2006
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series C
Investors
Finistere Ventures (Lead Investor) (Jerry Caulder)
Proceeds Purpose
Athenix plans to use the proceeds to continue moving products from their broad portfolio through field trials to registration.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
108 T.W. Alexander Dr.
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
Athenix is a leading biotechnology company developing innovative, high-value, bio-industrial products for the Agricultural and Chemical businesses using genetic traits from microbes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Koziel
Chief Financial Officer
Mark Hahn
Chief Operating Officer
Markus Andres
VP - Bus. Development
Scott Uknes
VP - Product Management
Nadine Carozzi
VP - R & D
Nicholas Duck
Browse more venture capital transactions:
Prev: 1/5/2006: XDx venture capital transaction
Next: 1/6/2006: Loadstar Sensors venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs